Financial Statements
30. Financial instruments
The system used by the Bayer Group to manage credit risk, liquidity risk and the various types of market risks (interest-rate risk, currency risk and other price risks), together with its objectives, methods and procedures, is outlined in the Risk Report, which forms part of the Management Report.
30.1 Information on financial instruments by category
Loans and receivables and liabilities carried at amortized cost also include receivables and liabilities under finance leases where Bayer is the lessor or lessee and which therefore have to be measured in accordance with IAS 17.
The fair value of receivables, loans, held-to-maturity financial investments and primary liabilities is measured as the present value of future cash inflows or outflows, discounted at a current interest rate as of the closing date and taking into account the due date of assets or remaining term of liabilities and the rating of Bayer AG. Where a market price is available, this is taken as the fair value.
Because of the short maturities of most trade accounts receivable and payable, other receivables and liabilities, and cash and cash equivalents, the net carrying amounts at the balance sheet date do not differ significantly from the fair values.
Income, expense, gains and losses on financial instruments can be assigned to the following categories:
The fair value of receivables, loans, held-to-maturity financial investments and primary liabilities is measured as the present value of future cash inflows or outflows, discounted at a current interest rate as of the closing date and taking into account the due date of assets or remaining term of liabilities and the rating of Bayer AG. Where a market price is available, this is taken as the fair value.
Because of the short maturities of most trade accounts receivable and payable, other receivables and liabilities, and cash and cash equivalents, the net carrying amounts at the balance sheet date do not differ significantly from the fair values.
Income, expense, gains and losses on financial instruments can be assigned to the following categories:
| 2007 | ||||||
| € million | Loans and receiv- ables | Held-to- maturity invest- ments | Available- for-sale financial assets | Held for trading (deri- vatives only) | Liabilities carried at amortized cost | Total |
| Interest income | 243 | 9 | 9 | 114 | 350 | 725 |
| Interest expense | - | - | - | (107) | (1,288) | (1,395) |
| Income from affiliated companies | - | - | - | - | - | - |
| Changes in fair value | - | - | - | 1 | - | 1 |
| Impairment charges | (107) | - | (27) | - | - | (134) |
| Income from write-backs | 83 | - | - | - | - | 83 |
| Gains/losses from retirements | - | - | 1 | - | - | 1 |
| Other non-operating income and expense | 12 | - | (1) | - | 1 | 12 |
| Net result | 231 | 9 | (18) | 8 | (937) | (707) |
| 2006 | ||||||
| € million | Loans and receiv- ables | Held-to- maturity invest- ments | Available- for-sale financial assets | Held for trading (deri- vatives only) | Liabilities carried at amortized cost | Total |
| Interest income | 206 | 17 | 15 | 259 | 140 | 637 |
| Interest expense | - | - | - | (306) | (1,030) | (1,336) |
| Income from affiliated companies | - | - | 5 | - | - | 5 |
| Changes in fair value | - | - | - | (4) | - | (4) |
| Impairment charges | (140) | - | (20) | - | - | (160) |
| Income from write-backs | 102 | - | - | - | - | 102 |
| Gains/losses from retirements | - | - | 19 | - | - | 19 |
| Other non-operating income and expense | (4) | - | - | - | (1) | (5) |
| Net result | 164 | 17 | 19 | (51) | (891) | (742) |
The column headed “Held for trading” consists almost entirely of interest income and expenses relating to interest-rate and cross-currency interest-rate hedges that do not qualify for hedge accounting (see Note [13.2]).
30.2 Maturity analysis
As of the reporting date, the liquidity risk to which the Bayer Group was exposed from its financial instruments comprises obligations relating to future interest and repayment installments for financial liabilities and the liquidity risk arising from derivative financial instruments, as shown in this table.
The carrying amount of bonds includes €2,285 million (2006: €2,276 million) for the mandatory convertible bond. This includes future interest payments but not repayment installments.
The carrying amount of bonds includes €2,285 million (2006: €2,276 million) for the mandatory convertible bond. This includes future interest payments but not repayment installments.
30.3 Accounting for derivative financial instruments
The Bayer Group uses derivative financial instruments to mitigate the risk of changes in exchange rates, interest rates and commodity prices. Many transactions constitute economic hedges but do not qualify for hedge accounting under IAS 39 (Financial Instruments: Recognition and Measurement). Changes in the fair value of these derivative financial instruments are recognized directly in the income statement. Fair value changes from forward exchange contracts and currency options are reflected in exchange gains and losses, those from interest-rate swaps and interest-rate options in interest income and expense, and those from commodity futures and commodity options in other operating income and expenses.
The fair values of derivative financial instruments are measured by the usual methods in light of the market data available at the measurement date. Currency and commodity contracts are measured individually at their forward rates or forward prices on the balance sheet date. These depend on spot prices including time spreads. The fair values of interest-rate hedging instruments are determined by discounting future cash flows over the remaining terms of the instruments at market rates of interest. The present value of each interest-rate, currency or cross-currency interest-rate swap transaction is measured individually as of the balance sheet date. Interest income is recognized in the income statement at the date of payment or, in case of accrual, at the balance sheet date. Certain long-term commodity contracts to which fair values cannot be assigned are measured with the aid of valuation models based on internal fundamental data.
The fair values of derivative financial instruments are measured by the usual methods in light of the market data available at the measurement date. Currency and commodity contracts are measured individually at their forward rates or forward prices on the balance sheet date. These depend on spot prices including time spreads. The fair values of interest-rate hedging instruments are determined by discounting future cash flows over the remaining terms of the instruments at market rates of interest. The present value of each interest-rate, currency or cross-currency interest-rate swap transaction is measured individually as of the balance sheet date. Interest income is recognized in the income statement at the date of payment or, in case of accrual, at the balance sheet date. Certain long-term commodity contracts to which fair values cannot be assigned are measured with the aid of valuation models based on internal fundamental data.
The income and expense reflected in the non-operating result pertaining to the derivatives and the underlying transactions are shown separately. Income and expense are not offset.
Fair value hedges
Fair value hedges are used to eliminate the risk of changes in fair value, especially on fixed-interest borrowings, by obtaining a variable interest rate. Essentially these fair value hedges relate to the €2 billion bond issued in 2002 and the €1.3 billion bond issued in 2005.
The ineffective portion of fair value hedges amounts to €1 million (2006: €3 million).
Cash flow hedges
Fluctuations in future cash flows from forecasted foreign currency transactions are avoided by designating cash flow hedges. Cash flow hedges are also used to partially limit exposure to fluctuations in future cash flows resulting from price changes on procurement markets. Such cash flow hedges relate to forecasted transactions or the risk of price fluctuations in procurement transactions with total notional volumes of €1,294 million and €293 million (2006: €1,761 million and €389 million), respectively.
Other comprehensive income increased by €124 million in 2007 (2006: €43 million decrease) due to positive changes in the fair values of derivatives designated as cash flow hedges. Income of €65 million (2006: expense of €11 million) was released from other comprehensive income to other operating income and expenses. Pro-rated deferred taxes of €19 million (2006: expense of €3 million), previously recognized in other comprehensive income, was transferred to deferred tax expenses. No ineffective portions of hedges had to be recognized in the income statement in 2007 (2006: €5 million).
An amount of €22 million (2006: €38 million) is expected to be reclassified from other comprehensive income to the income statement during 2008. The realization of all forecasted transactions is considered highly probable.
The market values of contracts existing at year end in the major categories were as follows:
Fair value hedges are used to eliminate the risk of changes in fair value, especially on fixed-interest borrowings, by obtaining a variable interest rate. Essentially these fair value hedges relate to the €2 billion bond issued in 2002 and the €1.3 billion bond issued in 2005.
The ineffective portion of fair value hedges amounts to €1 million (2006: €3 million).
Cash flow hedges
Fluctuations in future cash flows from forecasted foreign currency transactions are avoided by designating cash flow hedges. Cash flow hedges are also used to partially limit exposure to fluctuations in future cash flows resulting from price changes on procurement markets. Such cash flow hedges relate to forecasted transactions or the risk of price fluctuations in procurement transactions with total notional volumes of €1,294 million and €293 million (2006: €1,761 million and €389 million), respectively.
Other comprehensive income increased by €124 million in 2007 (2006: €43 million decrease) due to positive changes in the fair values of derivatives designated as cash flow hedges. Income of €65 million (2006: expense of €11 million) was released from other comprehensive income to other operating income and expenses. Pro-rated deferred taxes of €19 million (2006: expense of €3 million), previously recognized in other comprehensive income, was transferred to deferred tax expenses. No ineffective portions of hedges had to be recognized in the income statement in 2007 (2006: €5 million).
An amount of €22 million (2006: €38 million) is expected to be reclassified from other comprehensive income to the income statement during 2008. The realization of all forecasted transactions is considered highly probable.
The market values of contracts existing at year end in the major categories were as follows:
| Dec. 31, 2006 | Dec. 31, 2007 | |||||
| Fair value | Fair value | |||||
| € million | Notional amount | Positive fair value | Negative fair value | Notional amount | Positive fair value | Negative fair value |
| Currency hedging of recorded transactions | 10,305 | 78 | (29) | 5,523 | 136 | (54) |
| Forward exchange contracts | 8,960 | 40 | (19) | 4,572 | 77 | (24) |
| of which FV hedges | 0 | 0 | 0 | 0 | 0 | 0 |
| of which CF hedges | - | - | - | - | - | - |
| Currency options | 76 | 2 | (1) | 34 | 2 | (1) |
| of which FV hedges | 0 | 0 | 0 | 0 | 0 | 0 |
| of which CF hedges | - | - | - | - | - | - |
| Cross-currency interest-rate swaps | 1,269 | 36 | (9) | 917 | 57 | (29) |
| of which FV hedges | 0 | 0 | 0 | 0 | 0 | 0 |
| of which CF hedges | 965 | 33 | (9) | 874 | 57 | (29) |
| Currency hedging of forecasted transactions | 1,761 | 54 | (4) | 1,294 | 69 | (7) |
| Forward exchange contracts | 1,761 | 54 | (4) | 1,294 | 69 | (7) |
| of which FV hedges | - | - | - | - | - | - |
| of which CF hedges | 1,201 | 51 | (2) | 1,273 | 68 | (7) |
| Currency options | 0 | 0 | 0 | 0 | 0 | 0 |
| of which FV hedges | - | - | - | - | - | - |
| of which CF hedges | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest rate hedging of recorded transactions | 11,633 | 110 | (157) | 8,703 | 99 | (183) |
| Interest rate swaps | 10,633 | 106 | (156) | 7,703 | 95 | (183) |
| of which FV hedges | 5,708 | 22 | (145) | 1,719 | 7 | (69) |
| of which CF hedges | - | - | - | - | - | - |
| Interest rate options | 1,000 | 4 | (1) | 1,000 | 4 | 0 |
| of which FV hedges | - | - | - | - | - | - |
| of which CF hedges | - | - | - | - | - | - |
| Commodity price hedging | 389 | 137 | (225) | 293 | 247 | (219) |
| Forward commodity contracts | 323 | 76 | (149) | 208 | 86 | (70) |
| of which FV hedges | 0 | 0 | 0 | 0 | 0 | 0 |
| of which CF hedges | 72 | 2 | (70) | 8 | 2 | (1) |
| Commodity option contracts | 66 | 61 | (76) | 85 | 161 | (149) |
| of which FV hedges | - | - | - | - | - | - |
| of which CF hedges | - | - | - | - | - | - |
| Total | 24,088 | 379 | (415) | 15,813 | 551 | (463) |
| of which short-term derivative financial instruments | 15,484 | 135 | (57) | 6,071 | 180 | (79) |
| for currency hedging | 11,101 | 103 | (31) | 5,878 | 142 | (30) |
| for interest rate hedging | 4,127 | 0 | (4) | 0 | 0 | 0 |
| for commodity hedging | 256 | 32 | (22) | 193 | 38 | (49) |



Chairman’s Letter
Notes
Bayer Links
Investor Relations


Bookmark this page
E-mail this page
Advanced Search

